Shares in Proton beam therapy specialist Advanced Oncotherapy (AVO) have been suspended from trading on AIM after talks to raise an additional £8m in funding collapsed. The company said it was now in a ‘highly constrained financial position and requires additional financing urgently in order to continue as a going concern’. AVO had been in…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2026 All rights reserved LaingBuisson
 have been suspended from trading on AIM after talks to raise an additional £8m in funding collapsed.){kind=link}